Physician profile
Carson C Bauder
NPI 1528265949
$8,433.11
in general payments reported to CMS, 2019-2025
8 companies · $1,943 in 2025
The $1,943 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,955 · 2020: $151 · 2021: $722 · 2022: $393 · 2023: $2,118 · 2024: $1,152 · 2025: $1,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,949 · Travel and Lodging: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,948.69 |
| Travel and Lodging | $1,264.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $4,746.04 | 2019-2025 | Xeomin |
| Lumenis Be INC | $1,050.98 | 2025 | M22 |
| Allergan, INC. | $963.90 | 2019-2022 | |
| Abbvie INC. | $673.54 | 2023-2025 | Botox |
| Revance Therapeutics, INC. | $636.78 | 2024-2025 | Daxxify, Daxi |
| Tela Bio, INC. | $189.77 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $158.07 | 2024 | In.Pact Admiral |
| Novo Nordisk INC | $14.03 | 2023 | Novoeight, Novoseven |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Bauder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.